Daniel Hume - Net Worth and Insider Trading

Daniel Hume Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel Hume owns 3 companies in total, including TG Therapeutics Inc (TGTX) , Stemline Therapeutics Inc (STML) , and National Holdings Corp (NHLD) .

Click here to see the complete history of Daniel Hume’s form 4 insider trades.

Insider Ownership Summary of Daniel Hume

Ticker	Comapny	Transaction Date	Type of Owner
TGTX	TG Therapeutics Inc	2020-06-22	director
STML	Stemline Therapeutics Inc	2020-06-10	director
NHLD	National Holdings Corp	2020-04-02	director

Daniel Hume Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Daniel Hume Ownership Network

Ownership Network List of Daniel Hume

No Data

Ownership Network Relation of Daniel Hume

Daniel Hume Owned Company Details

What does TG Therapeutics Inc do?

Who are the key executives at TG Therapeutics Inc?

Daniel Hume is the director of TG Therapeutics Inc. Other key executives at TG Therapeutics Inc include CFO & Secretary and Treasurer Sean A Power , director & CEO and President Michael S Weiss , and 10 percent owner Ra Capital Management, L.p. .

TG Therapeutics Inc (TGTX) Insider Trades Summary

Over the past 18 months, Daniel Hume made no insider transaction in TG Therapeutics Inc (TGTX). Other recent insider transactions involving TG Therapeutics Inc (TGTX) include a net sale of 69,500 shares made by Laurence N Charney , a net sale of 121,514 shares made by Sean A Power , and a net sale of 39,854 shares made by Sagar Lonial .

In summary, during the past 3 months, insiders sold 27,000 shares of TG Therapeutics Inc (TGTX) in total and bought 0 shares, with a net sale of 27,000 shares. During the past 18 months, 230,868 shares of TG Therapeutics Inc (TGTX) were sold and 109,000 shares were bought by its insiders, resulting in a net sale of 121,868 shares.

TG Therapeutics Inc (TGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

TG Therapeutics Inc Insider Transactions

No Available Data

What does Stemline Therapeutics Inc do?

Who are the key executives at Stemline Therapeutics Inc?

Daniel Hume is the director of Stemline Therapeutics Inc. Other key executives at Stemline Therapeutics Inc include Chief Operating Officer Kenneth Hoberman , and Chief Medical Officer Eric K Rowinsky .

Stemline Therapeutics Inc (STML) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Stemline Therapeutics Inc (STML) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Stemline Therapeutics Inc (STML) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Stemline Therapeutics Inc (STML)'s detailed insider trading history can be found in Insider Trading Tracker table.

Stemline Therapeutics Inc Insider Transactions

No Available Data

What does National Holdings Corp do?

Who are the key executives at National Holdings Corp?

Daniel Hume is the director of National Holdings Corp. Other key executives at National Holdings Corp include 10 percent owner Daniel Asher , President and CFO Glenn C. Worman , and Chief Operating Officer John C. Desena .

National Holdings Corp (NHLD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of National Holdings Corp (NHLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of National Holdings Corp (NHLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

National Holdings Corp (NHLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

National Holdings Corp Insider Transactions

No Available Data

Daniel Hume Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel Hume. You might contact Daniel Hume via mailing address: 3 Columbus Circle, 15th Floor, New York Ny 10019.

Discussions on Daniel Hume

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.